Market Outperform - Price 16.21 on Dec. 21 by JMP Securities We are maintaining our 12-month price target of $21. DiamondRock Hospitality announced today that it had sold the 220-room SpringHill Suites Atlanta Buckhead for $36 million to a private-equity firm. The purchase price implies a cap rate of 5.5% on trailing 13-period (trailing 12-month) net operating income, a great price for DRH that should be very accretive. The sale also reduces the company's exposure to the Atlanta market from four hotels to three (Atlanta Marriott Alpharetta, Renaissance Waverly and Westin Atlanta Perimeter North)...DiamondRock remains our top REIT pick, and we believe this deal is just another indication of the company's savvy and quality management team... Including the current dividend yield of 5.9% (versus the sector average of 7.2%), our target price indicates a total 12-month return of 35%.

Outperform - Price 38.12 on Dec. 21 by Cowen and Co. McAfee filed its past-due 2006 and 2007 10-Qs and 10-Ks on Friday afternoon [Dec. 21]. We found no major surprises, although detailed cash flows do point to more positive impact on billings from exchange-rate movements, something that is hard to predict and non-operational. With the restatement behind it, we expect the company to resume share repurchases, albeit offset to some degree initially by significant employee option exercise activity. We believe shares can outperform the market by 15% over the next 12 months.

Buy - Price 6.25 on Dec. 19 by Hilliard Lyons We are raising our rating to Buy from Neutral, with a $10-$12 target price. We believe both of Sypris' segments, Sypris Industrial Group and Sypris Electronic Group, are poised to improve in 2008 and 2009, leading to double-digit revenue growth, higher margins, and free cash flow. [The company provides outsourced manufacturing and services to the aerospace and defense industries as well to the trucking and automotive industries.] Valuation is also compelling, in our view. The share price is over a $4 discount to the firm's $10.55 book value at the end of 3Q07. Further, we believe a breakup value also supports a higher price. We believe both units individually are worth at least $5-$6 per share, and that the board of directors should consider such an alternative unless the share price rises significantly over the next year.

Buy - Price 24.26 on Dec. 26 by B. Riley & Co With its "Youth Against Establishment" motto, Volcom is one of the leading youth board sports/California lifestyle apparel, footwear and accessory vendors that targets the core independent, speciality retail and department store channels...In the domestic segment, the company has recently suffered from a shrinking business with its largest customer, Pacific Sunwear of California...Although we expect near-term results to reflect the current transitional nature of the business with PSUN, the company has an opportunity to profitably grow its business...We are initiating coverage with a Buy rating and $34 target.

Outperform - Price 46.48 on Dec. 26 by Friedman, Billings, Ramsey & Co. On Dec. 24, Teva announced it had launched generic pantoprazole (Wyeth's Protonix) and raised its EPS guidance for 2007 to $2.34-$2.36. We estimate initial shipment of generic pantoprazole [a treatment for acid reflux] of $150 million... We are increasing our EPS estimates for 2007 and 2008 to $2.35 from $2.32 and to $2.69 from $2.65, respectively... Our new price target [is] 53, up from our prior 52 target.

BUY - Price 13.99 on Dec. 26 Merriman Curhan Ford & Co. VCG announced today the acquisition of the 12,000-square-foot LaBoheme Gentlemen's Cabaret in Denver...VCG is in the enviable position of representing one of the only exit strategies for the 3,800 strip clubs in the U.S. We expect management to take advantage of its access to capital to fuel the expansion of its distinct brands to take additional share. With FY08 and FY09 EPS projected to increase by 75% and 39%... [we see the shares] yielding potential appreciation to the 24-30 range.